[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Nielsen, S., White, M., Hong, S., et al. (2016) The Breast-Thyroid Cancer Link: A Systematic Review and Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 25, 231-238.
https://doi.org/10.1158/1055-9965.EPI-15-0833
|
[3]
|
Joseph, K., Edirimanne, S. and Eslick, G. (2015) The Association between Breast Cancer and Thyroid Cancer: A Meta-Analysis. Breast Cancer Research and Treatment, 152, 173-181. https://doi.org/10.1007/s10549-015-3456-6
|
[4]
|
Beatson, G. (1896) On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases. Transactions Medico-Chirurgical Society of Edinburgh, 15, 153-179.
|
[5]
|
Chalstrey, L. and Benjamin, B. (1966) High Incidence of Breast Cancer in Thyroid Cancer Patients. British Journal of Cancer, 20, 670-675. https://doi.org/10.1038/bjc.1966.78
|
[6]
|
Nio, Y., Iguchi, C., Itakura, M., et al. (2009) High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-Like Disorders. Anticancer Research, 29, 1607-1610.
|
[7]
|
Izkhakov, E., Barchana, M., Liphshitz, I., et al. (2017) Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel. Thyroid, 27, 793-801. https://doi.org/10.1089/thy.2016.0481
|
[8]
|
Do, B., Payne, R., Bastianelli, M., et al. (2014) Is Age Associated with Risk of Malignancy in Thyroid Cancer? Otolaryngology—Head and Neck Surgery, 151, 746-750. https://doi.org/10.1177/0194599814547503
|
[9]
|
Amin, M.B., Edge, S., Greene, F., et al. (2017) AJCC Cancer Staging Manual. Springer International Publishing, New York. https://doi.org/10.1007/978-3-319-40618-3_2
|
[10]
|
Orosco, R., Hussain, T., Brumund, K., et al. (2015) Analysis of Age and Disease Status as Predictors of Thyroid Cancer-Specific Mortality Using the Surveillance, Epidemiology, and End Results Database. Thyroid, 25, 125-132.
https://doi.org/10.1089/thy.2014.0116
|
[11]
|
Adam, M., Thomas, S., Hyslop, T., et al. (2016) Exploring the Relationship between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. Journal of Clinical Oncology, 34, 4415-4420. https://doi.org/10.1200/JCO.2016.68.9372
|
[12]
|
Kaliszewski, K., Diakowska, D., Nowak, Ł., et al. (2020) The Age Threshold of the 8th Edition AJCC Classification Is Useful for Indicating Patients with Aggressive Papillary Thyroid Cancer in Clinical Practice. BMC Cancer, 20, 1166.
https://doi.org/10.1186/s12885-020-07636-0
|
[13]
|
Chen, A., Levy, L., Goepfert, H., et al. (2001) The Development of Breast Carcinoma in Women with Thyroid Carcinoma. Cancer, 92, 225-231. https://doi.org/10.1002/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO;2-B
|
[14]
|
Kuo, J., Chabot, J. and Lee, J. (2016) Breast Cancer in Thyroid Cancer Survivors: An Analysis of the Surveillance, Epidemiology, and End Results-9 Database. Surgery, 159, 23-29. https://doi.org/10.1016/j.surg.2015.10.009
|
[15]
|
Shin, C., Roh, J., Song, D., et al. (2020) Prognostic Value of Tumor Size and Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma. American Journal of Surgery, 220, 925-931. https://doi.org/10.1016/j.amjsurg.2020.02.020
|
[16]
|
Liu, L., Oh, C., Heo, J., et al. (2018) Clinical Significance of Extrathyroidal Extension According to Primary Tumor Size in Papillary Thyroid Carcinoma. European Journal of Surgical Oncology, 44, 1754-1759.
https://doi.org/10.1016/j.ejso.2018.05.009
|
[17]
|
Cheng, W., Shen, X. and Xing, M. (2019) Decreased Breast Cancer-Specific Mortality Risk in Patients with a History of Thyroid Cancer. PLoS ONE, 14, e0221093. https://doi.org/10.1371/journal.pone.0221093
|
[18]
|
Lei, K., He, X., Yu, L., et al. (2019) Breast Cancer Prognosis Is Better in Patients Who Develop Subsequent Metachronous Thyroid Cancer. PLoS ONE, 14, e0215948. https://doi.org/10.1371/journal.pone.0215948
|
[19]
|
Li, S., Yang, J., Shen, Y., et al. (2019) Clinicopathological Features, Survival and Risk in Breast Cancer Survivors with Thyroid Cancer: An Analysis of the SEER Database. BMC Public Health, 19, 1592.
https://doi.org/10.1186/s12889-019-7947-y
|
[20]
|
Park, C., Lee, Y., Oh, E., et al. (2014) The Prognosis and Treatment of Primary Thyroid Cancer Occurred in Breast Cancer Patients: Comparison with Ordinary Thyroid Cancer. Annals of Surgical Treatment and Research, 86, 169-176.
https://doi.org/10.4174/astr.2014.86.4.169
|